Hot Penny Stocks to Buy in 2021? Check These 7 Out Right Now
With July only a week away, which penny stocks are investors watching right now?
The post Hot Penny Stocks to Buy in 2021? Check These 7 Out Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
As we inch closer toward July, the market for both penny stocks and blue chips is heating up. This is illustrated by higher than average volume and several consistent gainers across the board. While the last two months of trading penny stocks has not been easy, many investors believe that there is a light at the end of the tunnel. With Covid cases hitting new lows and staying that way, we could see the finish line of the pandemic shortly.
Obviously, there are worries about long-term inflation, and we have to consider the massive volatility of the cryptocurrency market right now. However, all of these are adding fuel to the large swings of penny stocks and the stock market as a whole. With this in mind, here are seven hot penny stocks to watch in 2021.
Ocugen Inc. is a biotech penny stock creating gene therapies to cure blindness-related diseases. One of its main products is OCU400, which is a novel gene therapy product candidate that restores retinal integrity and function in those with both retinitis pigmentosa and Leber congenital amaurosis. It also has OCU410 which is a gene therapy candidate to treat dry age-related macular degeneration.
Ocugen currently is partnered with Bharat Biotech, which is creating a vaccine candidate for COVID-19. It has currently been reported that this “Covaxin” product shows 77.8% efficacy in protecting against COVID-19. This data was submitted to the Drugs Controller General of India over the weekend. This vaccine candidate is also on track for potential emergency use listing from the World Health Organization.
If this were to take place, it would definitely be solid news for both parties. When 2021 started, OCGN stock price was at about $3 per share on average. Now on June 24th, this penny stock is at $8 per share on average. While it isn’t necessarily a penny stock right now, it has been for quite some time before its recent upticks. In the past six months, shares have shot up by over 263%, making OCGN a perfect example of a company that traversed penny stock territory. With this in mind, will it be on your watchlist?
Uranium Energy Corp. (NYSE: UEC)
Uranium Energy Corp. is a mining penny stock that explores, extracts, and processes uranium and titanium concentrate. The US based company owns an interest in the Palangana mine, Burke Hollow, Goliad, Longhorn, and more. The majority of its mining projects are located in Texas, Arizona, Colorado, Canada, and Paraguay.
On June 9th, Uranium Energy Corp. filed its fiscal 2021 third-quarter report. As of April 30th, the company held $132.4 million in cash, equity, and physical holdings. This is comprised of $47.9 million in cash, uranium inventory holdings of $26.2 million, and 14 million shares of Uranium Royalty Corp. with a market value of $49.3 million. This vast uranium stockpile is one of the reasons that so many investors are interested in UEC stock.
Only six months ago this penny stock was at $1.76 per share on average. Now UEC stock price is at nearly $3 per share on average. All of this momentum shows how well the mining sector has been performing lately. So keeping all of this recent information in mind, will you add UEC to your list of penny stocks to watch?
Kelso Technologies Inc. (NYSE: KIQ)
An industrial penny stock that has been performing well recently is Kelso Technologies Inc. This company develops, produces, and distributes proprietary equipment used in transportation applications. It offers products such as railway equipment, tank gauges, lab test equipment, emergency response kits, and much more. It also provides trucking components such as one-bolt man-ways and pressure/vacuum safety valves.
There is no recent company-specific news that is making KIQ stock go up. But what can be assumed is that as COVID-19 restrictions loosen around the world, industrial companies can operate at a full capacity. This means that equipment is being used close to pre-covid levels.
KIQ stock is also frequently mentioned on Reddit, notably on r/RobinhoodPennyStocks and r/WallStreetbetsELITE. Could this be the reason that KIQ stock has a higher volume right now than its average? Well, that’s tough to say but what we do know is that this penny stock has increased by over $0.10 per share in the last month. So with this in mind, KIQ could be worth keeping an eye on in 2021.
ENGlobal Corporation (NASDAQ: ENG)
ENGlobal Corporation is another industrial penny stock that has been performing well in the market. This company has two sections, one being EPCM and the other being automation. Its EPCM section gives multi-disciplined engineering services related to developing, managing, and executing projects that need professional engineers. Its automation sector offers design, integration, and implementation of process distributed control, analyzer systems, and more.
On June 7th the latest update was released from ENGlobal Corporation. The company announced that after U.S. markets close on Friday, June 25th, it will join the Russell Microcap Index. This one-year membership provides automatic inclusion in the appropriate growth and value style indexes.
“We are pleased to have been selected for addition to the Russell Microcap® Index. We believe this addition validates the stability of our business and our future business prospects and will be an added opportunity for us to heighten investor awareness as we work to build shareholder value.”
Chief Executive at ENGlobal Mark Hess
This is big news and could bring a great deal of attention to ENG stock. Considering this, it could be worth watching right now.
Progenity Inc. (NASDAQ: PROG)
Progenity Inc. is a biotech penny stock that has been gaining momentum in recent trading sessions. The company develops and commercializes molecular testing products, which are in high demand right now. Progenity’s Innatal product provides noninvasive prenatal screening to women in early pregnancy to see chromosome abnormalities. It has a large variety of other product candidates as well.
Progenity caught recent attention as it now offers COVID-19 PCR testing services. Companies that create COVID-19 related products recently have been seeing more attention than others. This could explain why PROG stock is trading at more than 4 times its average volume right now.
Recently, the company participated in the Raymond James 2021 Human Health Innovation conference. The company also announced a $40 million private placement at the start of June. The net proceeds will be used to support operations, invest in molecular testing research and development, and much more. PROG stock was at $2.49 per share one month ago. Now on June 24th, PROG’s stock price is at $3.56 per share on average. So will you add PROG to your list of penny stocks to watch in 2021?
Invesco Mortgage Capital Inc. (NYSE: IVR)
The real estate market has taken off in the last year, fueled by the pandemic. This means that penny stocks like Invesco Mortgage Capital Inc. have been increasing in market value. This company is a real estate investment trust (REIT). Its main focus is investing in, financing, and managing mortgage-backed securities and other mortgage-related assets.
On June 23rd the company announced its quarterly common dividend. The cash dividend of $0.09 per share will be paid on July 27th to stockholders on record as of July 6th. Other than this, the company has not released any recent updates. So why is IVR stock performing so well in the market right now?
Well, this can be attributed to the real estate boom in the United States right now. Invesco has experienced a lot of positive momentum as real estate property value rises. 6 months ago the company was at $3.35 per share on average. As of June 24th, IVR stock is at $4.10 per share on average. So will this penny stock make your watchlist this week?
Ambev S.A. (NYSE: ABEV)
Ambev S.A. is a beverage penny stock that produces, distributes, and sells carbonated soft drinks and beer as well as food products. Some of the brands it sells are Gatorade, Lipton, Pepsi, Seven Up, among many others. These products are offered in the Americas, Brazil, Central America, the Caribbean, and more. During both times of economic hardship and prosperity, companies that produce beverages and alcohol specifically, tend to do quite well.
Throughout the pandemic, Ambev has been a major performer across the market. In addition, it recently announced that it would be working to electrify its massive fleet of delivery vehicles. While this doesn’t necessarily make it an EV penny stock, it does show that ABEV is working to keep up with the times. Other than this, there have not been any recent updates from Ambev S.A. despite it consistently moving up in the last month. Considering its sizable role in the beverage industry worldwide, ABEV stock could be worth keeping an eye on.
Which Penny Stocks Are You Watching?
As we move further toward the end of the year, plenty of penny stocks are showing potential. With so much movement occurring in the past few weeks, investors can take advantage of this high volatility. Considering this, which penny stocks are you watching?
Mathematicians use AI to identify emerging COVID-19 variants
Scientists at The Universities of Manchester and Oxford have developed an AI framework that can identify and track new and concerning COVID-19 variants…
Scientists at The Universities of Manchester and Oxford have developed an AI framework that can identify and track new and concerning COVID-19 variants and could help with other infections in the future.
Scientists at The Universities of Manchester and Oxford have developed an AI framework that can identify and track new and concerning COVID-19 variants and could help with other infections in the future.
The framework combines dimension reduction techniques and a new explainable clustering algorithm called CLASSIX, developed by mathematicians at The University of Manchester. This enables the quick identification of groups of viral genomes that might present a risk in the future from huge volumes of data.
The study, presented this week in the journal PNAS, could support traditional methods of tracking viral evolution, such as phylogenetic analysis, which currently require extensive manual curation.
Roberto Cahuantzi, a researcher at The University of Manchester and first and corresponding author of the paper, said: “Since the emergence of COVID-19, we have seen multiple waves of new variants, heightened transmissibility, evasion of immune responses, and increased severity of illness.
“Scientists are now intensifying efforts to pinpoint these worrying new variants, such as alpha, delta and omicron, at the earliest stages of their emergence. If we can find a way to do this quickly and efficiently, it will enable us to be more proactive in our response, such as tailored vaccine development and may even enable us to eliminate the variants before they become established.”
Like many other RNA viruses, COVID-19 has a high mutation rate and short time between generations meaning it evolves extremely rapidly. This means identifying new strains that are likely to be problematic in the future requires considerable effort.
Currently, there are almost 16 million sequences available on the GISAID database (the Global Initiative on Sharing All Influenza Data), which provides access to genomic data of influenza viruses.
Mapping the evolution and history of all COVID-19 genomes from this data is currently done using extremely large amounts of computer and human time.
The described method allows automation of such tasks. The researchers processed 5.7 million high-coverage sequences in only one to two days on a standard modern laptop; this would not be possible for existing methods, putting identification of concerning pathogen strains in the hands of more researchers due to reduced resource needs.
Thomas House, Professor of Mathematical Sciences at The University of Manchester, said: “The unprecedented amount of genetic data generated during the pandemic demands improvements to our methods to analyse it thoroughly. The data is continuing to grow rapidly but without showing a benefit to curating this data, there is a risk that it will be removed or deleted.
“We know that human expert time is limited, so our approach should not replace the work of humans all together but work alongside them to enable the job to be done much quicker and free our experts for other vital developments.”
The proposed method works by breaking down genetic sequences of the COVID-19 virus into smaller “words” (called 3-mers) represented as numbers by counting them. Then, it groups similar sequences together based on their word patterns using machine learning techniques.
Stefan Güttel, Professor of Applied Mathematics at the University of Manchester, said: “The clustering algorithm CLASSIX we developed is much less computationally demanding than traditional methods and is fully explainable, meaning that it provides textual and visual explanations of the computed clusters.”
Roberto Cahuantzi added: “Our analysis serves as a proof of concept, demonstrating the potential use of machine learning methods as an alert tool for the early discovery of emerging major variants without relying on the need to generate phylogenies.
“Whilst phylogenetics remains the ‘gold standard’ for understanding the viral ancestry, these machine learning methods can accommodate several orders of magnitude more sequences than the current phylogenetic methods and at a low computational cost.”
Journal
Proceedings of the National Academy of Sciences
DOI
10.1073/pnas.2317284121
Article Title
Unsupervised identification of significant lineages of SARS-CoV-2 through scalable machine learning methods
While the size of the United States makes it hard for it to compete with the inter-city train access available in places like Japan and many European countries, Amtrak trains are a very popular transportation option in certain pockets of the country — so much so that the country’s national railway company is expanding its Northeast Corridor by more than one million seats.
Running from Boston all the way south to Washington, D.C., the route is one of the most popular as it passes through the most densely populated part of the country and serves as a commuter train for those who need to go between East Coast cities such as New York and Philadelphia for business.
Veronika Bondarenko captured this photo of New York’s Moynihan Train Hall.
Veronika Bondarenko
Amtrak launches new routes, promises travelers ‘additional travel options’
Earlier this month, Amtrak announced that it was adding four additional Northeastern routes to its schedule — two more routes between New York’s Penn Station and Union Station in Washington, D.C. on the weekend, a new early-morning weekday route between New York and Philadelphia’s William H. Gray III 30th Street Station and a weekend route between Philadelphia and Boston’s South Station.
According to Amtrak, these additions will increase Northeast Corridor’s service by 20% on the weekdays and 10% on the weekends for a total of one million additional seats when counted by how many will ride the corridor over the year.
“More people are taking the train than ever before and we’re proud to offer our customers additional travel options when they ride with us on the Northeast Regional,” Amtrak Executive Vice President and Chief Commercial Officer Eliot Hamlisch said in a statement on the new routes. “The Northeast Regional gets you where you want to go comfortably, conveniently and sustainably as you breeze past traffic on I-95 for a more enjoyable travel experience.”
Here are some of the other Amtrak changes you can expect to see
Amtrak also said that, in the 2023 financial year, the Northeast Corridor had nearly 9.2 million riders — 8% more than it had pre-pandemic and a 29% increase from 2022. The higher demand, particularly during both off-peak hours and the time when many business travelers use to get to work, is pushing Amtrak to invest into this corridor in particular.
To reach more customers, Amtrak has also made several changes to both its routes and pricing system. In the fall of 2023, it introduced a type of new “Night Owl Fare” — if traveling during very late or very early hours, one can go between cities like New York and Philadelphia or Philadelphia and Washington. D.C. for $5 to $15.
As travel on the same routes during peak hours can reach as much as $300, this was a deliberate move to reach those who have the flexibility of time and might have otherwise preferred more affordable methods of transportation such as the bus. After seeing strong uptake, Amtrak added this type of fare to more Boston routes.
The largest distances, such as the ones between Boston and New York or New York and Washington, are available at the lowest rate for $20.
I am a conservation biologist who studies emerging infectious diseases. When people ask me what I think the next pandemic will be I often say that we are in the midst of one – it’s just afflicting a great many species more than ours.
I am referring to the highly pathogenic strain of avian influenza H5N1 (HPAI H5N1), otherwise known as bird flu, which has killed millions of birds and unknown numbers of mammals, particularly during the past three years.
This is the strain that emerged in domestic geese in China in 1997 and quickly jumped to humans in south-east Asia with a mortality rate of around 40-50%. My research group encountered the virus when it killed a mammal, an endangered Owston’s palm civet, in a captive breeding programme in Cuc Phuong National Park Vietnam in 2005.
How these animals caught bird flu was never confirmed. Their diet is mainly earthworms, so they had not been infected by eating diseased poultry like many captive tigers in the region.
This discovery prompted us to collate all confirmed reports of fatal infection with bird flu to assess just how broad a threat to wildlife this virus might pose.
This is how a newly discovered virus in Chinese poultry came to threaten so much of the world’s biodiversity.
Until December 2005, most confirmed infections had been found in a few zoos and rescue centres in Thailand and Cambodia. Our analysis in 2006 showed that nearly half (48%) of all the different groups of birds (known to taxonomists as “orders”) contained a species in which a fatal infection of bird flu had been reported. These 13 orders comprised 84% of all bird species.
We reasoned 20 years ago that the strains of H5N1 circulating were probably highly pathogenic to all bird orders. We also showed that the list of confirmed infected species included those that were globally threatened and that important habitats, such as Vietnam’s Mekong delta, lay close to reported poultry outbreaks.
Mammals known to be susceptible to bird flu during the early 2000s included primates, rodents, pigs and rabbits. Large carnivores such as Bengal tigers and clouded leopards were reported to have been killed, as well as domestic cats.
Our 2006 paper showed the ease with which this virus crossed species barriers and suggested it might one day produce a pandemic-scale threat to global biodiversity.
In the past couple of years, bird flu has spread rapidly across Europe and infiltrated North and South America, killing millions of poultry and a variety of bird and mammal species. A recent paper found that 26 countries have reported at least 48 mammal species that have died from the virus since 2020, when the latest increase in reported infections started.
Not even the ocean is safe. Since 2020, 13 species of aquatic mammal have succumbed, including American sea lions, porpoises and dolphins, often dying in their thousands in South America. A wide range of scavenging and predatory mammals that live on land are now also confirmed to be susceptible, including mountain lions, lynx, brown, black and polar bears.
The UK alone has lost over 75% of its great skuas and seen a 25% decline in northern gannets. Recent declines in sandwich terns (35%) and common terns (42%) were also largely driven by the virus.
Scientists haven’t managed to completely sequence the virus in all affected species. Research and continuous surveillance could tell us how adaptable it ultimately becomes, and whether it can jump to even more species. We know it can already infect humans – one or more genetic mutations may make it more infectious.
At the crossroads
Between January 1 2003 and December 21 2023, 882 cases of human infection with the H5N1 virus were reported from 23 countries, of which 461 (52%) were fatal.
Of these fatal cases, more than half were in Vietnam, China, Cambodia and Laos. Poultry-to-human infections were first recorded in Cambodia in December 2003. Intermittent cases were reported until 2014, followed by a gap until 2023, yielding 41 deaths from 64 cases. The subtype of H5N1 virus responsible has been detected in poultry in Cambodia since 2014. In the early 2000s, the H5N1 virus circulating had a high human mortality rate, so it is worrying that we are now starting to see people dying after contact with poultry again.
It’s not just H5 subtypes of bird flu that concern humans. The H10N1 virus was originally isolated from wild birds in South Korea, but has also been reported in samples from China and Mongolia.
Recent research found that these particular virus subtypes may be able to jump to humans after they were found to be pathogenic in laboratory mice and ferrets. The first person who was confirmed to be infected with H10N5 died in China on January 27 2024, but this patient was also suffering from seasonal flu (H3N2). They had been exposed to live poultry which also tested positive for H10N5.
Species already threatened with extinction are among those which have died due to bird flu in the past three years. The first deaths from the virus in mainland Antarctica have just been confirmed in skuas, highlighting a looming threat to penguin colonies whose eggs and chicks skuas prey on. Humboldt penguins have already been killed by the virus in Chile.
How can we stem this tsunami of H5N1 and other avian influenzas? Completely overhaul poultry production on a global scale. Make farms self-sufficient in rearing eggs and chicks instead of exporting them internationally. The trend towards megafarms containing over a million birds must be stopped in its tracks.
To prevent the worst outcomes for this virus, we must revisit its primary source: the incubator of intensive poultry farms.
Diana Bell does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
Cookie
Duration
Description
cookielawinfo-checbox-analytics
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional
11 months
The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy
11 months
The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
